Ge Healthcare Technologies (GEHC) Stock
Global medical technology company for imaging and patient monitoring. Here's the price, business snapshot, and what's worth knowing about Ge Healthcare Technologies in September 2026.
GE HealthCare Technologies Inc. (GEHC) is a global medical technology and services company focused on diagnostic imaging, ultrasound, patient monitoring, life‑sciences tools and bioprocessing, and healthcare IT. With a market capitalisation around $34.7 billion, the business combines capital equipment sales with recurring revenue from service contracts, consumables and software – a mix that can smooth cyclicality in equipment purchases. Key growth drivers include demand for imaging and diagnostics, expansion of bioprocessing for biologics, and adoption of digital and AI tools to improve workflows. Investors should be aware of sensitivity to hospital and clinic capital spending cycles, competitive pressures, reimbursement and regulatory risk, and supply‑chain dynamics. Management execution and capital allocation also matter for returns. This summary is educational only, not personalised advice: values can rise and fall and past performance is not a guide to the future. Check up‑to‑date filings and consult a financial adviser when assessing suitability for your portfolio.
Why It’s Moving
GE HealthCare Boosts Dividend by 14% and Adds AT&T CFO to Board Amid Ongoing Legal Scrutiny
- The Board of Directors declared a cash dividend of $0.04 per share for the third quarter of 2026, representing a 14% increase from the previous quarter, payable on November 13, 2026.
- Pascal Desroches, Senior Executive Vice President and CFO of AT&T, has been appointed to the GE HealthCare Board of Directors effective January 4, 2027, bringing over 30 years of experience in finance and digital transformation.
- Multiple law firms continue to investigate potential violations of federal securities laws regarding GE HealthCare, urging shareholders who incurred losses to contact legal counsel.
GE HealthCare Boosts Dividend by 14% and Adds AT&T CFO to Board Amid Ongoing Legal Scrutiny
- The Board of Directors declared a cash dividend of $0.04 per share for the third quarter of 2026, representing a 14% increase from the previous quarter, payable on November 13, 2026.
- Pascal Desroches, Senior Executive Vice President and CFO of AT&T, has been appointed to the GE HealthCare Board of Directors effective January 4, 2027, bringing over 30 years of experience in finance and digital transformation.
- Multiple law firms continue to investigate potential violations of federal securities laws regarding GE HealthCare, urging shareholders who incurred losses to contact legal counsel.
Sixth Month Growth Performance
When is the next earnings date for GE HEALTHCARE TECHNOLOGIES INC (GEHC)?
GE HealthCare Technologies (GEHC) is expected to report its next earnings on October 28, 2026. The release is expected to cover the company’s fiscal third quarter of 2026. The date remains an estimate pending formal confirmation by GE HealthCare.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying GE Healthcare's stock, with a target price indicating significant potential growth.
Financial Health
GE Healthcare is showing strong revenue and cash flow, indicating solid financial stability and performance.
Dividend
GE Healthcare’s low dividend yield of 0.22% suggests limited income for investors. If you invested $1000 you would be paid $2.20 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Diagnostics and Imaging
Imaging equipment drives sales and higher‑margin service revenue; technological upgrades and AI could support demand, though hospital budgets and reimbursement affect timing.
Life Sciences Growth
Bioprocessing and tools for biologics offer expansion opportunities as biologics production rises, but competition and capital intensity can affect margins.
Global Service Network
Recurring revenue from service contracts and consumables provides stability and customer ties, yet geographic exposure and supply chains can influence performance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
